Inman BA - Search Results

1

Maintenance bacillus Calmette-Guérin: why is there continued debate?

Inman BA, Abern MR. Inman BA, et al. Eur Urol. 2013 Oct;64(4):586-7. doi: 10.1016/j.eururo.2013.05.055. Epub 2013 Jun 11. Eur Urol. 2013. PMID: 23773556 No abstract available.

2

Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.

Abern MR, Freedland SJ, Inman BA. Abern MR, et al. Among authors: inman ba. BJU Int. 2013 Feb;111(2):187-8. doi: 10.1111/j.1464-410X.2012.11331.x. Epub 2012 Jun 21. BJU Int. 2013. PMID: 22727145 No abstract available.

3

Interpreting a study on bladder cancer screening.

Inman BA, Abern MR. Inman BA, et al. Eur Urol. 2013 Jul;64(1):48-50. doi: 10.1016/j.eururo.2013.03.047. Epub 2013 Apr 11. Eur Urol. 2013. PMID: 23582948 No abstract available.

4

Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

Abern MR, Owusu RA, Anderson MR, Rampersaud EN, Inman BA. Abern MR, et al. Among authors: inman ba. J Natl Compr Canc Netw. 2013 Apr 1;11(4):477-84. doi: 10.6004/jnccn.2013.0060. J Natl Compr Canc Netw. 2013. PMID: 23584348 Review.

5

Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer.

Owusu RA, Abern MR, Inman BA. Owusu RA, et al. Among authors: inman ba. Biomed Res Int. 2013;2013:262313. doi: 10.1155/2013/262313. Epub 2013 Sep 1. Biomed Res Int. 2013. PMID: 24073396 Free PMC article. Review.

6

Clinical performance and utility of a DNA methylation urine test for bladder cancer.

Abern MR, Owusu R, Inman BA. Abern MR, et al. Among authors: inman ba. Urol Oncol. 2014 Jan;32(1):51.e21-6. doi: 10.1016/j.urolonc.2013.08.003. Urol Oncol. 2014. PMID: 24360662

7

Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.

Fantony JJ, Abern MR, Gopalakrishna A, Owusu R, Jack Tay K, Lance RS, Inman BA. Fantony JJ, et al. Among authors: inman ba. Urol Oncol. 2015 Sep;33(9):387.e1-6. doi: 10.1016/j.urolonc.2015.04.014. Epub 2015 May 28. Urol Oncol. 2015. PMID: 26027762

8

Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.

Fantony JJ, Longo TA, Gopalakrishna A, Owusu R, Lance RS, Foo WC, Inman BA, Abern MR. Fantony JJ, et al. Among authors: inman ba. Cancer Biomark. 2017;18(4):381-387. doi: 10.3233/CBM-160261. Cancer Biomark. 2017. PMID: 28106542

9

Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.

Lotan Y, Inman BA, Davis LG, Kassouf W, Messing E, Daneshmand S, Canter D, Marble HT, Joseph AM, Jewell S, Boorjian SA. Lotan Y, et al. Among authors: inman ba. J Urol. 2019 Nov;202(5):920-926. doi: 10.1097/JU.0000000000000355. Epub 2019 Oct 9. J Urol. 2019. PMID: 31120373 Clinical Trial.

10

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis.

Kamat AM, Lerner SP, O'Donnell M, Georgieva MV, Yang M, Inman BA, Kassouf W, Boorjian SA, Tyson MD, Kulkarni GS, Chang SS, Konety BR, Svatek RS, Balar A, Witjes JA. Kamat AM, et al. Among authors: inman ba. Eur Urol Oncol. 2020 Jun;3(3):318-340. doi: 10.1016/j.euo.2020.02.006. Epub 2020 Mar 20. Eur Urol Oncol. 2020. PMID: 32201133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page